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Changes in cell-surface glycan patterns are markers of the
presence of many different disease and cancer types, offering
a relatively untapped niche for glycan-targeting reagents and
therapeutics in diagnosis and treatment. Of paramount im-
portance for the success of any glycan-targeting reagent is
the ability to specifically recognize the target among the
plethora of different glycans that exist in the human body.
The preeminent technique for defining specificity is glycan
array screening, in which a glycan-binding protein (GBP)
can be simultaneously screened against multiple glycans.
Glycan array screening has provided unparalleled insight
into GBP specificity, but data interpretation suffers from dif-
ficulties in identifying false-negative binding arising from
altered glycan presentation, associated with the linker used to
conjugate the glycan to the surface. In this work, we model
the structure and dynamics of the linkers employed in the
glycan arrays developed by the Consortium for Functional
Glycomics. The modeling takes into account the physical
presence and surface polarity of the array, and provides a
structure-based rationalization of false-negative results
arising from the so-called “linker effect.” The results also
serve as a guide for interpreting glycan array screening data
in a biological context; in particular, we show that attempts to
employ natural amino acids as linkers may be prone to unex-
pected artifacts compromising glycan recognition.
Keywords: glycan array screening / glycan-binding
protein / glycan specificity / linker effects / molecular dynamics
Introduction
Glycans are involved in almost all essential processes in a cell’s
life cycle and are also key players in the onset and progression
of many diseases, such as viral and bacterial infection, acquired
and inherited diseases and many types of cancer (Dennis et al.
1999; Rudd et al. 2001; Varki et al. 2009a, b). The biological
function of glycans depends on their interactions with glycan-
binding proteins (GBPs), which include enzymes, lectins and
antibodies. The knowledge of the specificity and affinity of
GBPs is essential for illuminating the inner workings funda-
mental to glycobiology, and in the design of glycan-targeting
reagents and therapeutics. Currently, the predominant technique
used to determine GBP specificity is glycan array screening
(Paulson et al. 2006; Oyelaran and Gildersleeve 2009). Glycan
arrays consist of a series of glycans covalently conjugated, or
non-covalently adhered, to discrete locations on a solid support
surface. In covalent arrays, the glycans are often linked to the
surface via a synthetic linker. Screening typically consists of in-
cubating a labeled GBP on the array, followed by one or more
wash steps, with binding subsequently quantified using fluores-
cence detection. The types of support surfaces, as well as im-
mobilization techniques, and binding detection methods, vary
among glycan arrays (Paulson et al. 2006), as do the structures
of the glycans that are immobilized on the surface. It has been
observed (Lewallen et al. 2009; Padler-Karavani et al. 2012;
Tessier et al. 2013) that the type of linker used to immobilize
the glycan on the surface may affect the ability of a glycan to be
recognized by its cognate GBP. Linker-dependent false-
negative binding has been attributed to the influence of the
linker on the presentation of the glycan relative to the support
surface. Ideally, the linker would present the glycan in the same
way as it is found in natural conditions, but this is impossible
with nonnatural linkers and surfaces. While some linkers may
exhibit less presentation-related issues, these are difficult to an-
ticipate, and thus in an attempt to circumvent this problem, it is
common to use a variety of linker types to conjugate the same
glycan to the array surface.
One such array has been made publically available through
the Consortium for Functional Glycomics (CFG) (Blixt et al.
2004; Alvarez and Blixt 2006). In the latest version of the CFG
array, 21 different types of linkers are present, comprising
amino acids, peptides and nonnatural molecules, creating over
600 unique glycan-linker combinations.
In this work, we employ molecular dynamics (MD) simula-
tions of surface-conjugated glycans to gain insight into the role
of linker chemistry on glycan presentation. The exact chemical
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compositions of the silica-based support surfaces employed in
glycan arrays are poorly defined, in part because of a lack of
physical characterization data, compounded by the fact that
many surfaces have been chemically modified, for example by
PEGylation, prior to glycan conjugation (Alvarez and Blixt
2006). In order to avoid these issues, and yet provide useful in-
formation, MD simulations were performed with the linkers
attached to idealized hydrophilic and hydrophobic surfaces.
Both surface types were modeled using a flat layer of methanol
(MeOH) molecules in a 2D hexagonal packing arrangement.
One face of this surface is hydrophilic, while the other is hydro-
phobic (Figure 1). The shapes adopted by the linkers during
these simulations serve as the basis for determining whether
they are able to present a glycan for recognition by a GBP.
Linker-dependent false-negative binding has been recently
noted in data from glycan array screening of the antitumour anti-
body JAA-F11 (Tessier et al. 2013), which was raised against the
Thomsen–Friedenreich (TF) antigen (Rittenhouse-Diakun et al.
1998). Thus, we selected this system for a more detailed analysis
of linker effects. The “TF-antigen” or “T tumour antigen”
(Galβ1-3GalNAcα-Ser/Thr), which is also the mucin core 1 pre-
cursor in O-linked glycan biosynthesis, is normally hidden from
the immune system by extension at the 3- or 6-OH of the Galβ
residue and/or at the 6-OH of the α-galactosamine (GalNAcα)
residue. This process is disrupted during cancer, and the
TF-antigen has been shown to be expressed on the cell surfaces
of pancreatic, colon and breast cancers (Heimburg-Molinaro
et al. 2011). The TF antigen has been described as a pan-
carcinoma antigen after being found to be present in over 90% of
human carcinomas where its expression is associated with, and
has a functional role in, cancer metastasis (Yu 2007). JAA-F11 is
a murine monoclonal antibody that was raised against the
TF-antigen and has been shown to target and slow the progres-
sion of metastatic tumors in a mouse model (Heimburg et al.
2006).
When screened against the CFG glycan array v4.0, JAA-F11
showed binding only to TF-containing glycans on the CFG
array that were linked via a simple alkyl spacer (Sp8). The mAb
was unable to recognize the same TF-containing glycans if they
were attached to the array via threonine (Sp14) or a phenylene-
containing linker (Sp16). The primary objective of the present
work is to provide a structure-based rationalization of the false-
negative binding that can arise from these “linker-effects” in
glycan array screening. Our approach is based on the hypoth-
esis that the physical properties of the linker, the glycans and
the array surface are responsible for glycan recognition and that
these properties can be determined from molecular simulation.
Methods
System generation
The chemical sequences of the spacers used on the CFG array
were taken from the CFG website: www.functionalglycomics.
org. The 3D structure of each spacer (terminated with a methyl
group) was built using Maestro, a package contained within the
Schrodinger Software Suite (Suite 2011). In order to obtain
energy-optimized φ and ψ torsion angles, each spacer was also
built with a terminating GalNAcα and/or β-glucosamine
(GlcNAcβ) where necessary (Table I). During array fabrication,
the spacers are immobilized onto the surface via formation of
an amide bond with the n-hydroxysuccinimade-activated
surface (Blixt et al. 2004). A 3D structure for this “surface con-
jugation moiety” attached to a methanol was also generated
(Table I). The combination of surface conjugation moiety and
spacer constitutes a “linker.”
The resulting 3D structures were initially geometry opti-
mized using Argus Labs (Thompson) at the MNDO level of
theory using a BFGS search with a 10−3 kcal/mol/Å gradient
convergence criterion. These MNDO minima were further
geometry optimized at the HF/6-31++g(2d,2p) level in
Gaussian09 (Frisch et al. 2009). Atomic partial charges were
derived for the methyl terminating spacer structures by RESP
fitting (Bayly et al. 1993) to the quantum mechanical (QM) mo-
lecular electrostatic potential computed with the CHELPG
(Breneman and Wiberg 1990) sampling method at the HF/
cc-pVTZ level, in accordance with standard AMBER protocols
(Kirschner et al. 2008).
The reducing terminal carbohydrates most commonly found
on the CFG glycan array, GalNAcα and GlcNAcβ were built
using GLYCAM-Web (Woods Group 2005–2013) and attached
to the linkers using the tLEaP module of AMBER12 (Case
et al. 2012). Linkers that are present on the array attached to
glycans via both α- and β-linkages, or whose anomeric config-
uration was not specified, were modeled with both carbohy-
drates. Some linkers were found attached to glycans via only
one linkage type, and so only one model was necessary
(Table I). The glycosidic φ and ψ torsion angles were set
according to the geometry-optimized values. All of these struc-
tures were then exported from tLEaP as PDB files for attach-
ment to the model array surfaces.
Both a hydrophobic and a hydrophilic surface were modeled
using a flat layer of methanol (MeOH) molecules. The surfaces
were created with a computer script written in the C programing
language using the Glylib library of functions (Foley et al.).
The C–O bonds of the MeOH molecules were aligned parallel
to each other with all of the hydroxyl groups forming one face
and all of the methyl groups the other. The molecules were
located on a 2D hexagonal grid with an intermolecular spacing
of 5 Å. The number of MeOH molecules in the surface ranged
from a minimum of 19 to a maximum of 127, corresponding to
distances of from 10 to 30 Å between the central MeOH and
Fig. 1. Glycan-linker-surface models. Left: GalNAcα-Sp8 (stick, pink atom
coloring) on a hydrophilic surface (green, transparent) made from methanol
(stick, green atom coloring). Right: A hydrophobic surface (dark gray,
transparent) generated by inverting the methanol (stick, dark gray atom
coloring).
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the furthest vertex. Surface size was selected so as to ensure
that at its largest extension the glycan-linker did not protrude
beyond the edge of the surface.
The linker was attached to the hydroxyl oxygen atom of the
central MeOH. In the case of the hydrophobic surface, this
linking MeOH was inverted relative to the MeOH molecules
comprising the surface (Figure 1). Thus, in the hydrophilic
surface the glycan-linker could interact directly with the polar
hydroxyl groups, whereas in the hydrophobic case, it could
interact with the apolar methyl groups.
The glycan-linker-surface structure was solvated by TIP3P
(Jorgensen et al. 1983) water, using the tLEaP module of
AMBER12 (Case et al. 2012), with a 10 Å buffer and a contact
spacing of 0.5 Å between the solvent and solute van der Waals’
surfaces. Charged systems were neutralized by adding either
Na+ or Cl− counter ions as appropriate, again using tLEaP.
Molecular dynamics
All MD simulations were performed using the CUDA (Gotz
et al. 2012) implementation of PMEMD in the Amber12 software
suite (Case et al. 2012). The carbohydrate parameters were taken
from GLYCAM06h (Kirschner et al. 2008), while the
amber99SB force field (Hornak et al. 2006) was used to represent
the surface and linker portions. Any parameter missing from the
amber99SB force field was obtained from the General Amber
force field (Wang et al. 2004). Cutoffs of 10.0 Å for van der
Waals and of 8.0 Å for real-space electrostatics were employed.
Initial energy minimization (10,000 steps of steepest descent, fol-
lowed by 10,000 steps of conjugate gradient) was performed
with 100 kcal/mol/Å2 Cartesian restraints on all solute heavy
atoms to optimize the water molecules positions and orientations.
This minimization step was followed by heating phase (nPT)
where the system was brought from 5 to 300 K over 100 ps, fol-
lowed by 400 ps of equilibration at 300 K. Equilibration was fol-
lowed by a 100 ns production run, except for the simulations of
Sp20, Sp23, Sp24 and Sp25, in which production was performed
for 500 ns. Throughout all simulations, the heavy atoms of the
surface were restrained with 100 kcal/mol/Å2 Cartesian restraints.
Creation of 3D linker library
Post-processing of the trajectories was performed with the ptraj
module of AMBER12 (Case et al. 2012). For each glycan-
linker system, 50 uncorrelated linker shapes were selected at
regular intervals and combined from both the hydrophilic and
hydrophobic surface simulations.
Root mean squared fluctuation plots
The atomicfluct command in the cpptraj module of AMBER12
(Case et al. 2012) was used to generate root mean squared fluc-
tuation (RMSF) plots from 5,000 snapshots taken at regularly
Table I. Details of the linkers used on the CFG glycan arrays
Spacer Formulaa Anomerb Surface radius (Å)
Sp0 –NCCO– α/β 20
Sp8 –NCCCO– α/β 20
Sp9 –NCCCCCO– α/β 20
Sp10 –NCC(=O)N– α/β 10
Sp11 –NCC(=O)Nc1ccc(cc1)CO– αc 30
Sp12 (Asn)d –NC(C(=O)O)CC(=O)N– α/β 20
Sp13 (Gly)e –NCC(=O)O– β 10
Sp14 (Thr)d –NC(C(=O)O)C(C)O– α/β 10
Sp15 (Ser)d –NC(C(=O)O)CO– α 10
Sp16 –Nc1ccc(cc1)O– α 20
Sp17 –Nc1ccc(cc1)CO– βc 20
Sp18 –NCCCCCC(=O)NCCCO– β 30
Sp19f –Glu–Asn or –Asn–Lys α/β 20
Sp20 –Gly–Glu–Asn–Arg β 30
Sp21 –NCCON(C)– α/β 20
Sp22 –Asn–Ser–Thr β 20
Sp23 –NCCOCCOCCOCCOCCOCCO– β 30
Sp24 –Lys–Val–Ala–Asn–Lys–Thr α/β 30
Sp25 –Val–Ala–Asn–Lys α/β 30
Surface conjugation moietyg CO–CCCC(=O)– – –
aInterpreted from the formulae reported on the CFG website (see Supplementary data, Table SI). The chemical and amino acid type spacers are written as SMILES
strings with the restriction that the leftmost dash indicates where the spacer attaches to the surface conjugation moiety and the rightmost dash indicates where the
spacer attaches to the glycan. The residues of the peptide type spacers are reported using amino acid three letter codes and in each case the glycan is N-linked via the
asparagine (in boldface) side-chain. Each peptide’s C terminal is a free carboxylate and the spacer is attached to the surface conjugation moiety via the N terminus of
the leftmost amino acid.
bIf glycans on the array were attached to the spacer via both anomeric configurations or if the anomeric configuration was undefined by the CFG then models for
both α and β were generated.
cReported configuration is for Neu5Ac; the inverted configuration was used when modeling with GlcNAc or GalNAc.
dGlycan is attached to the spacer via the side-chain. The C terminal carboxylate is free.
eGlycan is attached to the spacer via the backbone C terminal carboxylate.
fSp19 is modeled as both EN (Sp19) and NK (Sp19a).
gThe surface conjugation moiety is connected to the central surface methanol (left side) and to the amino group present in each of the spacers. The atoms of surface
conjugation moiety and spacer constitute a linker.
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spaced intervals from the MD simulation. The RMSF data were
calculated for each atom in the spacer and surface conjugation
moiety that connect the glycan to the surface (i.e., the linker
backbone atoms) as well as the C1 and C4 atoms of the glycan.
The data were averaged for the atoms of the surface conjugation
moiety, the spacer and the glycan.
Isodensity surface generation
The grid command in ptraj was used to generate atomic spatial
distribution functions (SDFs) from 5,000 snapshots taken at
regularly spaced intervals from the MD simulation. A 50 Å
cubic grid was built at 0.5 Å spacing for binning the atomic
positions. The resulting SDFs were visualized as isodensity sur-
faces using chimera (Pettersen et al. 2004). Individual isoden-
sity surfaces of the C1 and C4 ring atoms of the reducing
terminal saccharide attached to each linker were generated and
combined to give an indication of the glycan presentation rela-
tive to the surface.
Grafting of linkers into JAA-F11
The 3D linker libraries of each of the Sp8, Sp14, Sp15 and
Sp16 and were grafted onto TF-antigen’s reducing terminal
residue, using a 3D structure of TF-antigen in complex with
JAA-F11 (Tessier et al. 2013). Any vdW overlaps between the
atoms in JAA-F11 and the linker were quantified and normal-
ized relative to the overlap of a buried carbon atom.
Results and discussion
Quantifying glycan presentation
The data from the MD simulations were employed to derive
average properties for the surface-linker-glycan combinations,
of relevance to glycan presentation. Specifically, the effective
linker length was computed, as the distance from the surface
methanolic oxygen atom, to which the linker is attached, to the
C1 atom of the glycan (Table II). This distance enables a direct
comparison to be made between linker chemical structure and
observed length. For example, the addition of a single methy-
lene group to Sp0 to form Sp8 lengthens the linker by on
average 1.3 Å, whereas the addition of three methylenes to
form Sp9 lengthens it by only 2.7 Å, far less than that expected
from simple linear chain extension (3.9 Å). As the linker
becomes longer and more flexible, this deviation from the fully
extended idealized conformation becomes more profound. For
example, in the case of Sp23, the additional five ethylene
glycol units, relative to Sp0, extends the linker by less than half
(6.5 Å) of the potential extension (16.7 Å), in accord with the
extensive disorder observed experimentally in polyethylene
glycol fragments conjugated to proteins (Pai et al. 2011).
Notably, the average linker lengths appear to be largely in-
sensitive to either the monosaccharide or to the polarity of the
surface; only in the case of the longest linkers (Sp24 and Sp25)
are the differences in length greater than 1 Å.
Differences in the elevation height can be observed as a func-
tion of surface type, with the GalNAcα giving rise to average
values of 7.9 and 8.6 Å, for hydrophilic and hydrophobic
Table II. Effective linker length and saccharide elevation height of GalNAcα and GlcNAcβ conjugated to linkers on both hydrophilic and hydrophobic surfaces
Linker GalNAcα GlcNAcβ
Hydrophilic Hydrophobic Hydrophilic Hydrophobic
<Length>a,b <Height>c <Length> <Height> <Length> <Height> <Length> <Height>
Sp0 8.3 (1.0)d 6.2 (1.7) 8.3 (1.1) 7.5 (1.6) 8.4 (1.1) 6.8 (2.0) 8.8 (0.8) 7.8 (1.5)
Sp8 10.0 (1.2) 8.1 (2.1) 9.6 (1.1) 8.5 (1.8) 9.7 (1.0) 7.2 (2.6) 9.8 (1.2) 8.8 (2.5)
Sp9 11.0 (1.7) 7.7 (2.8) 11.2 (1.5) 8.8 (2.6) 11.1 (1.5) 7.3 (3.2) 11.4 (1.4) 8.9 (3.0)
Sp10 8.5 (1.0) 7.0 (2.0) 9.0 (0.7) 8.5 (1.7) 8.7 (0.8) 7.7 (1.6) 8.6 (0.6) 8.2 (1.2)
Sp11 – – – – 12.9 (1.9) 8.5 (3.8) 13.5 (1.4) 8.5 (3.3)
Sp12 10.7 (0.7) 8.3 (2.1) 10.6 (0.9) 9.2 (1.9) 10.8 (0.7) 9.9 (2.0) 10.7 (0.7) 10.3 (2.0)
Sp13 – – – – 8.6 (1.0) 7.7 (1.8) 8.6 (0.7) 8.2 (1.3)
Sp14 8.1 (1.1) 5.9 (1.5) 8.1 (1.1) 7.1 (1.2) 9.0 (0.8) 7.7 (1.4) 8.8 (0.6) 7.7 (1.1)
Sp15 8.4 (1.1) 6.5 (1.9) 8.3 (1.1) 7.1 (1.7) – – – –
Sp16 11.3 (0.6) 9.3 (2.5) 10.5 (0.8) 6.6 (3.2) – – – –
Sp17 12.0 (1.1) 7.5 (3.0) 11.7 (1.1) 9.1 (2.3) – – – –
Sp18 – – – – 14.3 (2.6) 9.1 (4.0) 14.7 (2.2) 9.9 (3.9)
Sp19 10.8 (0.7) 8.3 (2.1) 9.7 (1.3) 8.4 (2.0) 11.0 (0.7) 9.8 (2.0) 10.0 (1.1) 8.8 (2.3)
Sp19a 12.4 (1.6) 9.0 (3.0) 12.6 (1.2) 9.0 (3.3) 12.3 (1.6) 9.0 (3.2) 12.1 (1.4) 9.7 (2.7)
Sp20 – – – – 14.1 (2.6) 11.2 (3.8) 13.8 (2.2) 10.3 (3.7)
Sp21 9.0 (1.2) 6.6 (1.7) 9.0 (1.0) 6.7 (1.6) 8.5 (1.4) 6.6 (2.2) 9.0 (1.3) 7.7 (2.1)
Sp22 – – – – 10.5 (1.1) 8.7 (2.5) 11.1 (0.6) 10.7 (1.6)
Sp23 – – – – 14.6 (4.3) 8.8 (4.1) 15.3 (4.3) 10.5 (4.5)
Sp24 16.5 (3.1) 11.1 (4.4) 16.4 (3.2) 12.7 (4.6) 15.3 (3.6) 12.6 (4.4) 16.9 (2.6) 13.1 (4.5)
Sp25 14.2 (2.3) 9.6 (3.5) 13.7 (2.7) 10.8 (3.6) 13.7 (3.0) 10.1 (3.9) 14.3 (2.4) 11.0 (3.8)
Range 8.1–16.5 5.9–11.1 8.1–16.4 6.7–12.7 8.5–15.3 6.6–12.6 8.6–16.9 7.7–13.1
aAveraging is indicated by angled brackets and is based on 5,000 evenly spaced snapshots from the MD simulation.
bDistance between the oxygen atom of central surface methanol and the C1 atom of the glycan, in Å.
cDistance between the array surface and the geometric centroid of the glycan ring atoms, in Å.
dStandard deviations are presented in parentheses. With 5,000 snapshots, and using maximum standard deviations of 4.3 and 4.6 for length and height respectively,
two values can be deemed statistically different (P = 0.001) if their difference is larger than 0.3 Å for either length or height.
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surfaces, respectively. These may be compared with values of
8.7 and 9.4 Å for GlcNAcβ. As in the case of linker length,
linker elevation was also relatively insensitive to the monosac-
charide type. The subtle increase in elevation in the case of
GlcNAcβ may be accounted for by the equatorial configuration
at C1, which tends to place the monosaccharide ring further
from the surface, compared with the axial (α) configuration.
Overall, in the hydrophilic surface simulations the monosac-
charide is closer to the surface by 0.7 Å. The aromatic linker,
Sp16, is a notable exception to this trend, displaying a strong
tendency to be closer to the hydrophobic surface (by 2.7 Å).
As expected, the degree of motion of each glycan-linker struc-
ture varies significantly with the length of the linker. For
example, a short linker, such as Sp0, displays an RMSF of 3–4 Å,
which can increase to approximately 8 Å for the longest linkers
(see Figure 2 and Supplementary data, Figures S1–S5). It is
notable that the extent of the linker motion is not exclusively de-
pendent on the number of atoms in the linker connecting the
glycan to the surface (i.e., the linker backbone atoms). Rather,
linker length and motional properties also depend on the chemical
structure of the linker, its interaction with solvent, and the surface
polarity.
In order to more effectively illustrate the presentation proper-
ties of the surface-linker-glycan combinations, the positions of
the C1 and C4 atoms were monitored over the course of the
MD simulation and plotted in three dimensions as isodensity
surfaces. The isodensity surfaces for the C1 and C4 atoms were
overlaid for each system, generating a total of 62 plots (Figure 3
and Supplementary data, Figures S6–S10). When presented in
this manner, the relative positions of the C1 and C4 atoms
provide an indication of the orientation of the glycan ring
throughout the simulations and complement the distance data
in Table II. Notably, the anomeric configuration at the reducing
terminus of the glycan has a pronounced effect on glycan pres-
entation, which was not captured fully in the data in Table II.
This feature is exemplified by comparing the simulations
of GalNAcα and GlcNAcβ linked to the surface via Sp0.
A β-linkage with Sp0 frequently places the C4 atom distal to a
hydrophilic surface, whereas the α-configuration leads to a
bimodal distribution in which the C4 atom is more often prox-
imal to the surface (Figure 3).
The type of surface can also have a pronounced effect on the
relative orientation of the glycan. This effect can be observed in
the GalNAcα-Sp0 plots where the C4 atom is frequently seen
to be closer to the surface than the C1 atom, indicating that this
glycan appears to interact much more with the hydrophilic
surface than with the hydrophobic surface. This surface polarity
effect is particularly apparent in the Sp16 simulation (Figure 3),
where the phenylene ring in the linker forms stacking interac-
tions with the hydrophobic surface, whereas the glycan is more
often orientated away from the surface in the hydrophilic
surface simulation. This phenomenon is also observed with the
simulation of GlcNAcβ-Sp11 and GalNAcα-Sp17, which both
contain phenylene rings but are longer than Sp16. With some
linkers the length and flexibility were so great that the distribu-
tions appear to be much less influenced by the surface polarity,
as observed for GlcNAcβ-Sp18.
Four amino acid linkers are present in the current CFG array
(Sp12, asparagine, Sp13, glycine, Sp14, threonine and Sp15
serine), which are linked to the surface via their N-termini and
are all conjugated to the glycan via their side-chains, with the ex-
ception of glycine. In the case of glycine, the glycan is connected
via the carboxylate. Because the amino acids project approxi-
mately perpendicularly from the array surface, their side-chains
are presented parallel to the surface. For residues with short side-
chains (Ser and Thr), this results in glycan-presentation that is
Fig. 2. Linker motion (RMSF) as a function of the number of atoms in the
spacer portion of the linker calculated for linkers attached to both hydrophilic
(gray circles) and hydrophobic (black diamonds) surfaces.
Fig. 3. Isodensity surfaces depicting the spatial distributions of the C1 (light
gray) and C4 (red) glycan atoms from 5,000 snapshots extracted from the MD
simulations. A single 3D structure of the glycan and linker, extracted from each
MD simulation, is shown (stick, navy blue).
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also approximately parallel to the surface. This orientation is in
contrast to what would be expected in a glycoprotein, in which
the glycosylated side-chains would be presented more or less
perpendicularly from the protein surface. In the case of the as-
paragine linker, its slightly greater length (relative to Ser and
Thr) as well as its amido functionality results in glycan that is ap-
proximately perpendicular. The glycine linker also tends to
present the glycan in a perpendicular orientation, presumably as
a result of the nonnatural conjugation via the terminal carboxyl-
ate. While some of these presentational properties might be
anticipated, the present analysis provides a unique method to
both predict and quantify their existence.
The peptide linkers used to represent N-linked glycosylation
sites on the CFG array are highly flexible and adopt a multitude
of different shapes (Figure 3). In a biological context, this may
be a good model for N-linked glycosylation occurring at flex-
ible N or C termini, but does not necessarily reflect the proper-
ties of N-linked glycosylation sites. A peculiar example is
Sp25, which in the hydrophilic simulation appears to prefer a
shape where the glycan is interacting with both the surface and
the peptide linker. Thus, care should be taken when interpreting
data from glycans linked to specific peptide sequences. An al-
ternative to this approach is to attach glycans to carrier proteins,
forming neoglycoproteins, which can be printed onto the array
surface (Oyelaran and Gildersleeve 2009) or to neoglycolipids
(Feizi et al. 1994). In principle, employing arrays of neoglycoli-
pids and neoglycoproteins for glycan presentation offers some
benefits over the use of flat polymeric surfaces; particularly, in
the sense that the polarity of the lipid or protein carrier is bio-
logically relevant. However, the use of nonnatural linkers
between the glycan and the biomolecule may again introduce
recognition artifacts. Further, the topology (convex, concave
etc.) of the site of glycosylation, in the case of a neoglycopro-
tein, may also impact on glycan presentation (Petrescu et al.
2004).
Assessing array binding
When considering array data, binding may be abrogated by
several properties of the system. A true binder is a ligand that
can be accommodated in the receptor protein, with a measur-
able affinity. A true nonbinder is a glycan which contains a
change to the structure of the glycan that prevents it from being
bound (Tessier et al. 2013). In contrast, false-negative binding
may occur if the linker shape cannot fit into the binding site
(linker-collision false-negative binding), or if the preferred
presentation of the linker relative to the array surface is such
that the glycan is effectively inaccessible to the protein
(presentation-dependent false-negative binding). Presented in
Table III are binding data for the JAA-F11 system, which illus-
trate such linker-related false-negative binding. Thus, in order
for a linker to facilitate binding, there are two key issues: First,
there must not be any large steric overlaps between the linker
and the receptor-binding site and, secondly, the linker must
orient the glycan relative to the surface so that the receptor can
bind the ligand in the correct way, without being inhibited by
the array surface (Figure 4).
Collisions between the protein and the array surface, which
may arise depending on linker conformation, were accounted
for if any protein Cα atom was predicted to penetrate the array
surface. These putative collisions were normalized as the per-
centage of Cα atoms predicted to be below the plane of the
array surface. In the case of a hydrophilic array, the surface was
defined by the plane containing the oxygen atoms; a similar
definition based on the carbon atoms of the methyl groups was
employed for the hydrophobic surface. It should be noted that
Table III. Comparison of experimental specificity data for mAb JAA-F11 with
TF-containing glycansa demonstrating a linker effect on the CFG v4.0 glycan
array
CFG array v4.0
ID
Glycan sequence Experimental
RFUb
Sp8 Sp14 Sp16 Sp8 Sp14 Sp16
131 278 132 Galβ1-3GalNAcα 98 0 0
127 128 –c Neu5Acα2-6(Galβ1-3)GalNAcα 78 0 –
159 158d – Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα 52 0 –
125 126d – GlcNAcβ1-6(Galβ1-3)GalNAcα 51 0 –
aThe TF-disaccharide portion of each glycan is in boldface.
bNormalized RFUs averaged over all protein concentrations (0.1, 5 and 200
μg/mL) and over multiple values for the same glycan, when present on the CFG
array.
cDashes indicate that glycan-linker combination is not present on the glycan
array.
dReducing anomeric configuration undefined on the CFG array, α-configuration
assumed for the CCG analysis.
Fig. 4. Top left: The linker portion of TF-Sp8 (stick, goldenrod atom coloring)
is tolerated in the binding site of the glycan-binding protein, JAA-F11 (surface,
cyan). Top right: The linker portion of TF-Sp16 is not tolerated in the binding
site of JAA-F11 (surface, cyan) due to overlaps with the side-chain of Tyr 34
(surface, transparent cyan). Bottom left: The linker portion of Sp8-TF (stick,
goldenrod atom coloring) presents the TF-antigen relative to the array surface
(disc, dark gray) so that JAA-F11 (surface, cyan) is able to bind. Bottom-right:
The linker portion of Sp14-TF (stick, goldenrod atom coloring) presents the
TF-antigen relative to the array surface (disc, dark gray) so that JAA-F11
(surface, cyan) is unable to access the glycan.
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any induced fit in the glycan or the receptor upon binding and
any effect of larger oligosaccharides on the dynamics of the
linker are neglected by this model.
Identification of linker-related false-negative binding
The data in Table III indicate that mAb JAA-F11 binds only to
TF-glycans that are linked to the array via Sp8. On examination,
several TF-containing glycans that do bind when immobilized
via Sp8 do not bind when conjugated via other linkers, for
example, the antibody does not bind to the TF-disaccharide if
the glycan is linked to the array via Sp14 or Sp16. These are
clearly evidence of false-negative linker-dependent effects. Sp14
and Sp16 are, therefore, incompatible with binding, either
because they are not tolerated in the binding site or because they
present the glycan in such a way that it is inaccessible to the
protein. To assess the ability of any given linker shape to fit into
the protein-binding site, the reducing terminal residue in the
bound glycan was superimposed onto the corresponding mono-
saccharide in the monosaccharide-linker structures obtained from
the MD simulations. The protein–ligand complex was then eval-
uated for the presence of any steric overlaps between the linker
and the protein surface (see Table IVand Figure 4, top right).
This analysis indicated that the rigid phenylene structure of
Sp16 does not adopt any conformations that could sterically fit
into the mAb-binding site. Similarly, the majority (90%) of
the conformations of Sp14 (Thr) are incapable of fitting into the
binding site. This is also predicted to be the case for Sp15
(Ser), although there are no relevant TF-containing glycans
linked via serine on the CFG array (v4.0). Notably, the simula-
tions predict that even for the noninterfering linker Sp8, only
37% of the conformations are compatible with binding. Thus,
it is not necessary for all linker conformations to be acceptable.
However, the main factor responsible for the lack of binding
of TF-linked via Sp14 appears to arise from unfavorable glycan
presentation. This is evident from the fact that only 2% of the
shapes of Sp14 permit the protein to bind without collisions
with the array surface (Figure 4, Bottom right). Sp15 appears to
be more acceptable than Sp14 in general; however, Sp8 is pre-
dicted to be a superior linker in each category.
The comparison between the most populated pose from the
hydrophilic simulations of Sp14 and Sp8 clearly demonstrates
the difference in glycan presentation (Figure 5). The curved
geometry of Sp14 presents the glycan toward the surface,
whereas Sp8 is perpendicular to, and orients the glycan away
from, the surface. O-linked mucin type glycans are commonly
found on intrinsically disordered protein regions (Nishikawa
et al. 2010). The orientation of an O-linked glycan on a threo-
nine residue is, therefore, possibly better represented by the
Sp8 linker than the Sp14 “threonine” linker (Figure 5).
Predictive reinterpretation of CFG v4.0 array screening
of JAA-F11
The glycan-binding preferences of JAA-F11 have been recently
interpreted from a structural perspective by employing a theor-
etical method termed computational carbohydrate grafting
(CCG) (Tessier et al. 2013). Using CCG, a library of 3D glycan
shapes for the TF-containing glycans on the CFG array (v4.0)
was created and searched for putative binding and nonbinding
glycans, based on their ability to fit into the binding site. The
screening was carried out by grafting the branches of the
TF-glycans onto a structure of the bound TF-disaccharide. If a
branch formed excessive overlaps with the protein-binding site,
it was predicted to be a non-binder. The CCG results were in
complete agreement with the glycan array screening data;
however, some inconsistencies in the experimental data were
noted as a function of linker type. Fortunately, several of the
JAA-F11 binding partners are conjugated to the CFG array via
multiple linker types (Table V, glycans 1–9) allowing linker
effects to be inferred from the data. In this work, we have pro-
vided a structure-based rationale for the observed linker effects,
using a modification of the CCG protocol, allowing reinterpret-
ation of the JAA-F11 glycan array data (Table V). All of the
false-negative data points in the CFG data for this system were
predicted to arise either from glycan presentation defects or
from physical incompatibility of the linker with the binding site
topology of the mAb. This analysis enabled us to predict that a
further two glycans (14 and 21), which are found conjugated
solely by Sp14, are probable binding partners for JAA-F11.
The ability to predict false negatives in glycan array data is
essential in order to fully define specificities and binding
motifs. In order to aid in the detection of linker-dependent
false-negative binding, array developers employ multiple linker
types for each glycan. However, given the high number of
linkers in use, it is likely unfeasible to include all permutations
of linker chemistry with any given glycan. An independent
Table IV. Results from grafting TF-linkers into the JAA-F11-binding site
Linker Tolerateda shapes
(hydrophilic,
hydrophobic)
Correctb glycan
orientation
(hydrophilic,
hydrophobic)
Permitc Binding
(hydrophilic,
hydrophobic)
Sp8 37 (16/21) 36 (15/21) 23 (8/14)
Sp14 11 (5/6) 2 (0/2) 1 (0/1)
Sp15 12 (4/8) 13 (5/8) 4 (1/3)
Sp16 0 31 (23/8) 0
aPercentage of linker shapes from the MD simulation that have less than one
carbon atom equivalent buried in the JAA-F11 surface, when superimposed
onto the reducing terminal of the co-complexed TF-antigen.
bPercentage of linker shapes from the MD simulation that present the glycan so
that JAA-F11 can bind without colliding with the array surface.
cPercentage of linker shapes that simultaneously satisfy both conditions in a and b.
Fig. 5. Orientation of the most populated shape from the hydrophilic surface of
GalNAcα conjugated via Sp8 (left side, stick model) and Sp14 (right side, stick
model).
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analysis that can predict false negatives can assist experimental-
ists by focusing effort on re-evaluating only a subset of key
glycans.
Conclusions
Glycan array screening has emerged as one of the preeminent
methods for defining the specificity of carbohydrate-binding
proteins. These arrays are frequently generated by immobilizing
glycans through synthetic or natural linkers to a surface, such as
glass or silica. The binding of proteins to immobilized glycans
has been shown to be sensitive to linker choice (Lewallen et al.
2009; Padler-Karavani et al. 2012; Tessier et al. 2013),
presumably as a result of differences in the 3D presentation of
the glycan.
Here, we have employed computational modeling to examine
the effect of linker structure and properties on glycan presenta-
tion, relative to both a hydrophilic and a hydrophobic surface.
The modeling provides a structural basis for interpreting and pre-
dicting the impact of linker choice on glycan recognition. We
have focused on the binding properties reported recently (Tessier
et al. 2013) for the anticarbohydrate mAb JAA-F11, against the
CFG glycan array (v4.0); however, the observations are relevant
to array design and screening data interpretation in general. The
impact of linker effects is likely accentuated in the case of small
glycans, such as TF, but false-negative binding has also been
attributed to linker effects in the binding of proteins to recogni-
tion motifs on the outer arms of larger glycans (Lewallen et al.
2009; Padler-Karavani et al. 2012).
The degree to which linker chemistry affects glycan presenta-
tion depends both on the length of the linker (shorter being
more likely to restrict access to the glycan), and on the orienta-
tion of the linker relative to the array surface. Presentation can
be influenced by nonspecific interactions between the linker
and the surface. This is evident in the case of hydrophobic
linkers (Sp11, Sp16 and Sp17) attached to hydrophobic sur-
faces, which prefer orientations parallel to the array surface,
thereby maximizing hydrophobic contacts. Glycan presentation
can also be altered by the 3D structure of the linker itself. For
example, linkers Sp14 (Thr) and Sp15 (Ser) are predicted to
prefer to orient the TF-glycan parallel to the array surface,
making it inaccessible to the JAA-F11 antibody. Further, the
results illustrate that certain relatively rigid linkers, such as
Sp16, can prevent binding because they make unfavorable
interactions with the protein surface. Finally, each glycan-
binding protein will have a unique sensitivity to presentation
effects by virtue of the variations in protein shape and binding
site topology. It is hoped that the present work provides both
the technique and motivation for array designers to perform a
linker assessment during the early stages of linker selection. We
have concluded with regard to the CFG linkers that Sp8, Sp9,
Sp12, Sp18, Sp20, Sp23 and Sp24, are highly flexible and/or
have good glycan presentation properties. In terms of surface
polarity, we have considered two extremes; a purely hydrophilic
and a purely hydrophobic surface. Neither is directly equivalent
to a real array surface, the details of which are poorly defined.
Nevertheless, the data permit us to conclude that increasing
surface hydrophobicity is likely to increase the presence of non-
specific interactions between the linker and or the glycan,
leading to glycan recognition artifacts.
In the case of mAb JAA-F11, the CFG array data could lead
to the initial conclusion that this mAb does not recognize
TF-antigen whenever the antigen is attached to threonine. Given
that this mAb does localize in tumor tissues in vivo, the implica-
tion would be that it must be binding to serine-linked TF.
However, our analysis suggests that the lack of binding to threo-
nine depends at least in part on the nature of the presentation of
TF-Thr on the array, and that if TF-Ser were present, it would
also exhibit attenuated binding. Thus, this mAb may bind to
more cancer-associated TF-linkages than indicated by the glycan
array data. Also noteworthy is the fact that JAA-F11 was raised
by immunization with TF-O-CH2CH2-S-CH2-CH2-NH-COCH2
Table V. Reinterpreted glycan array data for mAb JAA-F11 highlighting
predicted false-negatives
ID Array glycan Experimental
bindinga
1 Galβ1-3GalNAcα-Sp8 Yes
2 Galβ1-3GalNAcα-Sp16 Nod
3 Galβ1-3GalNAcα-Sp14 Nod
4 Neu5Acα2-6(Galβ1-3)GalNAcα-Sp8 Yes
5 Neu5Acα2-6(Galβ1-3)GalNAcα-Sp14 Nod
6 GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp8 Yes
7 GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
8 Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp8 Yes
9 Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
10 Neu5Acβ2-6(Galβ1-3)GalNAcα-Sp8 Yes
11 KDNα2-3Galβ1-3GalNAcα-Sp14 No
12 Neu5Acα2-6(Neu5Acα2-3Galβ1-3)GalNAcα-Sp14 No
13 Neu5Acα2-3Galβ1-4GlcNAcβ1-6(Neu5Acα2-3Galβ1-3)
GalNAcα-Sp14
No
14 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-6(Galβ1-3)
GalNAcα-Sp14
Nod
15 Fucα1-2Galβ1-3GalNAcα1-3(Fucα1-2)
Galβ1-4Glcβ-Sp0
No
16 GlcNAcβ1-2Galβ1-3GalNAcα-Sp8 No
17 Neu5Acα2-3Galβ1-3GalNAcα-Sp8 No
18 Fucα1-2Galβ1-3GalNAcα-Sp14 No
19 Neu5Acα2-3Galβ1-3GalNAcα-Sp14 No
20 Neu5Acα2-6(Neu5Acα2-3Galβ1-3)GalNAcα-Sp8 No
21 Neu5Acα2-3Galβ1-4GlcNAcβ1-6(Galβ1-3)
GalNAcα-Sp14
Nod
22 (3S)Galβ1-3GalNAcα-Sp8 No
23 Fucα1-2Galβ1-3GalNAcα-Sp8 No
24 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-6
(Neu5Acα2-3Galβ1-3)GalNAcb-Sp14
No
25 Fucα1-2Galβ1-3GalNAcα1-3(Fucα1-2)
Galβ1-4GlcNAcβ-Sp0
No
26 GalNAcα1-3(Fucα1-2)Galβ1-3GalNAcα1-3(Fucα1-2)
Galβ1-4GlcNAcβ-Sp0
No
27 GlcNAcβ1-3Galβ1-3GalNAcα-Sp8 No
28 Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4Glcc-Sp0 No
29 GlcNAcα1-4Galβ1-3GalNAcb-Sp14 No
30 Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcc-Sp0 No
31 6S(Neu5Acα2-3Galβ1-3)GalNAcα-Sp8 No
aBinders defined as having greater than 10% of maximal RFUs at each protein
concentrations (0.1, 5 and 200 μg/mL).
bReducing anomeric configuration undefined on the CFG array, α-configuration
assumed for the CCG analysis.
cReducing anomeric configuration undefined on the CFG array, both
configurations tested in the CCG analysis.
dHighlighted in grey are the predicted false negatives from the v4.0 CFG array
screening of JAA-F11.
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CH2-BSA (Rittenhouse-Diakun et al. 1998), whose “TF-O-CH2
CH2” portion is analogous to Sp8, and to the side-chain of
serine.
Supplementary data
Supplementary data for this article is available online at http://
glycob.oxfordjournals.org/.
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